TickerFacts.

Processa Pharmaceuticals, Inc. (PCSA): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2015-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$125.9K
Year ended 2015-12-31
$188.0K2012-12-31: $133.3K2013-12-31: $188.0K2014-12-31: $66.8K2015-12-31: $125.9K$125.9K
2012-12-31 Cost of Revenue (USD) 2015-12-31
Period endedCost of RevenueChange YoYSource filing
2015-12-31$125.9K+88.3%2017-09-25, From 2015-01-01
2014-12-31$66.8Kn/c2017-06-19, From 2014-01-01
2013-12-31$188.0K+41.1%2015-04-14, From 2013-01-01
2012-12-31$133.3Kn/a2014-03-27, From 2012-01-01